ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
ns-MRAs and eGFR Slope: The Kidney Perspective
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
Mastering MRA Monitoring: The Key to Success
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
Gianluigi Savarese, MD
James Burton, DM, FRCP
Aaron Wong, MD
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
Summarizing multidisciplinary strategies: Where do we go from here?
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care
Pardeep Jhund, MD, PhD
Hiddo L. Heerspink, PhD
Orly Vardeny, MD
Muthiah Vaduganathan, MD, MPH
Nonsteroidal MRAs: The CKD/T1D Potential
MOA Deep Dive: The MRA Spectrum
Nonsteroidal MRAs: The CKD/T2D Advantage
Emerging Evidence in HF Care
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.